Back to search

Article

Different Doxorubicin Sensitivity Across Various Human Cancer Cell Lines

2024-10-20

Abstract excerpt

Doxorubicin (Dox) is a highly potent chemotherapeutic agent, approved by FDA since 1974, for treating a broad spectrum of cancers. However, development of severe side effects and drug resistance are main issues that limit the clinical use of Dox. Herein, we aimed to investigate the sensitivity of Dox in a variety of human cancer cell lines. Eleven cell lines were tested in this study including 2 hepatocellular car...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
29991b64-ad53-5bea-8846-6a2f7a611942
DOI
10.48048/tis.2024.8566
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Different Doxorubicin Sensitivity Across Various Human Cancer Cell LinesDOI 10.48048/tis.2024.8566
Drug sensitivity in cancer cell lines is not tissue-specificSemantic proximity
Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell linesSemantic proximity
Comparative Evaluation of the Cytotoxicity of Doxorubicin in BT-20 Triple-Negative Breast Carcinoma Monolayer and Spheroid CulturesSemantic proximity
Enhanced Antitumor Effects of Thymoquinone in Combination with Paclitaxel on Hepatocellular Carcinoma Cell Lines: Role of P53 ModulationSemantic proximity
Overcome Resistance in Doxorubicin-Adapted Hodgkin Lymphoma Cells With Acquired Multidrug Resistance and Improved Immunosuppressive AbilitiesSemantic proximity
Establishment of doxorubicin-resistant human bladder cancer cell line (BUI-87/ADMR) and its mechanism of multidrug resistance.Semantic proximity
Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrationsSemantic proximity
Inhibition of the transmembrane transporter ABCB1 overcomes resistance to doxorubicin in patient-derived organoid models of HCCSemantic proximity
Human Drug Efflux Transporter ABCC5 Confers Acquired Resistance to Pemetrexed in Breast CancerSemantic proximity
p53-R248W evades doxorubicin mediated cell death through collective alteration in TOP2A and CYP1A1 genes in cancer cells.Semantic proximity
The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis.Semantic proximity
miR-197-5p increases Doxorubicin-mediated anticancer cytotoxicity of HT1080 fibrosarcoma cells by decreasing drug effluxSemantic proximity
Select a neighboring publication to make it the new centre.